Optimization of diagnostical algorithms for pediatric polyneuropathy: etiological classification and immunological assessment in genetic and acquired types

FULL TEXT:

Abstract

Introduction. The timely diagnosis of polyneuropathies in children is a pressing issue in modern pediatric neurology, where etiological differentiation and immunological assessment significantly increase diagnostic accuracy. The aim of the study was to develop a highly sensitive, combined diagnostic algorithm based on the evaluation of etiological factors and immunological status in children with inflammatory and hereditary polyneuropathies. Materials and Methods. To optimize the diagnostic algorithm, a combined scoring system was developed. An integrative diagnostic model, based on the z-standardized sum of CSF protein, IgG, CRP, and motor NCV indicators (z-CSF + z-IgG + z-CRP − z-NCV), was established to reliably differentiate between inflammatory and hereditary polyneuropathies. Statistical analysis was performed using GraphPad Prism 10 software. The normality of distribution was assessed using the Shapiro-Wilk test. This prospective-retrospective study was conducted from 2022 to 2025. A total of 105 children (aged 1–18) were divided into three groups: inflammatory polyneuropathy (n=45), hereditary polyneuropathy (n=30), and control (n=30). Clinical, immunological (IgG, IgM, IgA, CD3+/CD4+/CD8+, TNF-α, IL-6), electroneuromyography (ENMG), and genetic methods were employed. Results and Discussion. In the inflammatory group, a decreased CD4+/CD8+ ratio (1.20±0.35) was observed, along with a significant increase in IgG (14.58±3.33 g/L), TNF-α, and IL-6 levels (p<0.0001). No immunological changes were observed in the hereditary group. The combined diagnostic algorithm demonstrated high accuracy, with an AUC of 0.986. Conclusion. The developed combined algorithm allows for the reliable differentiation of inflammatory and hereditary polyneuropathies and is recommended for implementation in regional clinical practice.

About the Authors

List of references

Leonhard SE, Mandarakas MR, Gondim FA, Bateman K, Ferreira ML, Cornblath DR, van Doorn PA, Dourado ME, Hughes RA, Islam B, Kusunoki S. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology. 2019 Nov;15(11):671-83.

Yuki N, Hartung HP. Guillain–barré syndrome. New England Journal of Medicine. 2012 Jun 14;366(24):2294-304.

Van den Bergh PY, van Doorn PA, Hadden RD, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist‐Markens PH, Cornblath DR, Eftimov F, Goedee HS. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision. Journal of the Peripheral Nervous System. 2021 Sep;26(3):242-68.

Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. The Lancet Neurology. 2013 Dec 1;12(12):1180-8.

Willison HJ, Jacobs BC, van Doorn PA. Guillain-barre syndrome. The Lancet. 2016 Aug 13;388(10045):717-27.

Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. The Lancet Neurology. 2009 Jul 1;8(7):654-67.

Hughes RA, Cornblath DR. Guillain-barre syndrome. The Lancet. 2005 Nov 5;366(9497):1653-66.

Гуломов К. МУЛЬТИМОДАЛЬНЫЙ ПОДХОД К ДИАГНОСТИКЕ ПОЛИНЕЙРОПАТИЙ РАЗЛИЧНОГО ГЕНЕЗА У ДЕТЕЙ. Международный журнал научной педиатрии. 2025 Nov 4;4(5):1078-83.

Куренков АЛ, Кузенкова ЛМ, Бурсагова БИ, Пак ЛА, Подклетнова ТВ, Абдуллаева ЛМ. Современные подходы к диагностике и лечению хронической воспалительной демиелинизирующей полинейропатии у детей: обзор литературы. Медицинский оппонент. 2021(4 (16)):38-45.

Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot‐Marie‐Tooth disease subtypes and genetic testing strategies. Annals of neurology. 2011 Jan;69(1):22-33.

McMillan HJ, Kang PB, Jones HR, Darras BT. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series. Neuromuscular Disorders. 2013 Feb 1;23(2):103-11.

Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011 Mar 21;36(2):123-33.

Iancu Ferfoglia R, Guimarães‐Costa R, Viala K, Musset L, Neil J, Marin B, Léger JM. Long‐term efficacy of rituximab in IgM anti‐myelin‐associated glycoprotein neuropathy: RIMAG follow‐up study. Journal of the Peripheral Nervous System. 2016 Mar;21(1):10-4.

Rossor AM, Polke JM, Houlden H, Reilly MM. Clinical implications of genetic advances in Charcot–Marie–Tooth disease. Nature Reviews Neurology. 2013 Oct;9(10):562-71.

Макина ОВ, Туз ВВ, Петрова НА, Ларина ЕА, Батяева ММ. Диабетическая нейропатия у детей: сложности диагностики и тактики ведения. InИнновационные технологии в эндокринологии 2021 (pp. 108-108).

Korinthenberg R, Trollmann R, Felderhoff-Müser U, Bernert G, Hackenberg A, Hufnagel M, Pohl M, Hahn G, Mentzel HJ, Sommer C, Lambeck J. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence-and consensus-based guideline. European Journal of Paediatric Neurology. 2020 Mar 1;25:5-16.

Гайбиев АА, Джурабекова АТ, Шомуродова ДС. Особенности клинико-диагностических проявлений у детей с острой полинейропатии. Re-health journal. 2020(2-2 (6)):63-7.

How to Cite

Optimization of diagnostical algorithms for pediatric polyneuropathy: etiological classification and immunological assessment in genetic and acquired types. (2026). International Journal of Scientific Pediatrics, 5(3), 1341-1349. https://doi.org/10.56121/2181-2926-2026-5-3-1341-1349

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)


ISSN 2181-2926 (Online)